Navigation Links
New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients
Date:6/26/2010

3.2% vs 3.1%), and myalgia (2.1% vs 0.4%)
  • Adult patients with Type 2 Diabetes were: constipation (8.7% vs 2.0%), nasopharyngitis (4.1% vs 3.6%), dyspepsia (3.9% vs 1.4%), hypoglycemia (3.0% vs 2.3%), nausea (3.0% vs 1.4%), and hypertension (2.8% vs 1.6%)

  • Post-marketing experience: Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship:

    • Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol
    • Reduced International Normalized Ratio (INR) has been reported in patients receiving warfarin concomitantly with Welchol
    • Elevated thyroid-stimulating hormone (TSH) has been reported in patients receiving thyroid hormone replacement therapy

    Pregnancy

    Welchol is Pregnancy Category B.

    Please visit http://www.welchol.com/pdf/Welchol_PI.pdf for full Prescribing Information on Welchol.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

    For more information on Welchol, call 877-4-DSPROD (877-437-7763), or go to the Welchol web site at

    SOURCE Daiichi Sankyo
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
    2. ULORIC(R) (febuxostat) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout
    3. Solos Endoscopy, Inc.s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
    4. Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study
    5. 5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
    6. Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients
    7. IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
    8. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
    9. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
    10. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
    11. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
    (Date:9/19/2014)... DALLAS , September 19, 2014 ... Market by Equipment Type (Benchtop, Mobile, Industrial, & ... Others), Technology (Tray-style, Manifold, & Rotary) & Geography ... by MarketsandMarkets, defines and segments the lyophilization market ... regions with analyses and projections of the market ...
    (Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
    Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
    ... and UBM Canon,s Medical Device Media Group will co-host a ... component selection in an advanced medical system. Dubbed, S ... be led by industry expert Robert Hult. As the ... has nearly 40 years experience in the connector industry, with ...
    ... 2011 Herborium Group, Inc., (Pinksheets: HBRM) www.herborium.com ... following update today. Dr. Agnes Olszewski, Chairmen ... exciting times for our Company. Firstly, we have continued ... maintaining Herborium, Current Information Status– the highest ...
    Cached Medicine Technology:Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar 2Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar 3Herborium Group Shareholders Update 2Herborium Group Shareholders Update 3
    (Date:9/20/2014)... 6 Minutes to Skinny , a fat loss ... is showing men and women of all ages how they ... using simple 6-minute exercises and easy-to-follow lifestyle tips daily, has ... , “When it comes to losing body fat, unfortunately ... all people,” reports Michaels. “Metabolism plays a big role in ...
    (Date:9/20/2014)... 2014 Increases in household, construction ... waste treatment volumes. However, government regulations and higher ... landfill. According to IBISWorld industry analyst Alen Allday, ... aimed at reducing the volume of waste generated, ... recovered.” Still, a large proportion of waste generated ...
    (Date:9/20/2014)... September 20, 2014 As testosterone ... in federal court, Bernstein Liebhard LLP notes that ... (FDA) have voted overwhelmingly to recommend that prescription ... be subjected to further study in order to ... published on September 18th by Bloomberg.com, the panel ...
    (Date:9/20/2014)... 2014 (HealthDay News) -- As flu season approaches, the ... to get a flu shot and a checkup, according ... care doctor can vaccinate people against the flu, and ... have. Retail stores may provide flu shots for their ... Dr. Jorge Parada, medical director of infection prevention and ...
    (Date:9/20/2014)... (PRWEB) September 20, 2014 As ... http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgeries continue to ... insurer has announced plans to end coverage for ... its website last month, Harrisburg, Pennsylvania-based Capital BlueCross ... 1, 2014. The insurer said its decision was ...
    Breaking Medicine News(10 mins):Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3
    ... -- Revenue of $99.7 million, up 23.6% year-over-year or up 30.9% ... of $11.3 million or $0.32 per diluted share, compared to a ... Highlights: -- Revenue of $423.4 million, up 45.5% ... -- Net income of $24.0 million or $0.68 per diluted ...
    ... Johnson & Johnson/Basilea,s or Forest/Novexel,s Drug Could Be ... Report from AMR and Decision ResourcesMALVERN, Pa. and ... (AMR) and Decision Resources find that activity against ... attributes influencing surveyed physicians, antibiotic selection for the ...
    ... students react better to stress, are less fatigued, have more ,integrated, brains , , , , , ... , , , ... , , , ... VIDEO: , Fred Travis, lead author and director of MUM,s Center for Brain, ,Consciousness and ...
    ... The Board of the Walter and Eliza Hall Institute ... the Institute,s next Director.Announcing Professor Hilton,s appointment as Director-Designate, ... that the directorship of WEHI is among the most ... world. This fact had demanded the most rigorous global ...
    ... ON, Feb. 24 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: ... research and development of drug products delivered to and ... delivery technologies, today announced that Nuvo,s INSIGHT(TM) platform, developed ... fqubed, Inc., has been selected as one of four ...
    ... Hard-Pressed Business SectorKIRKLAND, Wash., Feb. 24 For people ... healthcare front. They can often insure themselves for less, ... can use company dollars for a tax-deductible plan for ... of the Board of LTC Financial Partners LLC (LTCFP), ...
    Cached Medicine News:Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:Activity Against Drug-Resistant Pathogens is One of the Leading Attributes Influencing Physicians' Antibiotic Selection for the Treatment of Inpatient Community-Acquired Pneumonia 2Health News:Activity Against Drug-Resistant Pathogens is One of the Leading Attributes Influencing Physicians' Antibiotic Selection for the Treatment of Inpatient Community-Acquired Pneumonia 3Health News:Transcendental Meditation buffers students against college stress: Study 2Health News:Transcendental Meditation buffers students against college stress: Study 3Health News:Transcendental Meditation buffers students against college stress: Study 4Health News:Transcendental Meditation buffers students against college stress: Study 5Health News:The Walter and Eliza Hall Institute Announces the Next Director 2Health News:The Walter and Eliza Hall Institute Announces the Next Director 3Health News:The Walter and Eliza Hall Institute Announces the Next Director 4Health News:Nuvo's High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist 2Health News:Nuvo's High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist 3Health News:Long Term Care Insurance for Business Owners & Executives: Tax Benefits Often Overlooked 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: